De Novo Palmitate Synthesis Supports Oncogenic Signalling and Tumor Growth Through Diverse Mechanisms: Implications for FASN-Targeted Therapeutics

Journal of Cell Signaling
doi 10.4172/2576-1471.1000124
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Inhibition of De Novo NAD+ Synthesis by Oncogenic URI Causes Liver Tumorigenesis Through DNA Damage

Cancer Cell
Cancer ResearchOncologyCell Biology
2014English

Growth Factor Signaling: Implications for Disease & Therapeutics

Journal of NeuroImmune Pharmacology
NeuroscienceAllergyImmunologyPharmacology
2014English

Molecular Mechanisms of Cardiovascular Toxicity of Targeted Cancer Therapeutics

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2010English

Targeted Therapeutics

Cell
BiochemistryGeneticsMolecular Biology
2011English

HIV Treatment: Mechanisms of Neurotoxicity and Implications for Targeted Therapy

Neurobehavioral HIV Medicine
DermatologyPsychiatryMental HealthInfectious DiseasesBehavioral Neuroscience
2012English

Novel Targeted Therapeutics for MEN2

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2018English

Signalling Growth Through Lipid Kinases

Biophysical Journal
Biophysics
2019English

The Diverse Oncogenic and Tumor Suppressor Roles of microRNA-105 in Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

RNA-Targeted Therapeutics

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy